1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Protein Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Antibody Drugs 1.2.3 Peptide Hormones 1.2.4 Blood Products 1.2.5 Enzymes 1.3 Market by Application 1.3.1 Global Protein Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Protein Drugs Market Perspective (2016-2027) 2.2 Protein Drugs Growth Trends by Regions 2.2.1 Protein Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Protein Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Protein Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Protein Drugs Industry Dynamic 2.3.1 Protein Drugs Market Trends 2.3.2 Protein Drugs Market Drivers 2.3.3 Protein Drugs Market Challenges 2.3.4 Protein Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Protein Drugs Players by Revenue 3.1.1 Global Top Protein Drugs Players by Revenue (2016-2021) 3.1.2 Global Protein Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Protein Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Protein Drugs Revenue 3.4 Global Protein Drugs Market Concentration Ratio 3.4.1 Global Protein Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Protein Drugs Revenue in 2020 3.5 Protein Drugs Key Players Head office and Area Served 3.6 Key Players Protein Drugs Product Solution and Service 3.7 Date of Enter into Protein Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Protein Drugs Breakdown Data by Type 4.1 Global Protein Drugs Historic Market Size by Type (2016-2021) 4.2 Global Protein Drugs Forecasted Market Size by Type (2022-2027) 5 Protein Drugs Breakdown Data by Application 5.1 Global Protein Drugs Historic Market Size by Application (2016-2021) 5.2 Global Protein Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Protein Drugs Market Size (2016-2027) 6.2 North America Protein Drugs Market Size by Type 6.2.1 North America Protein Drugs Market Size by Type (2016-2021) 6.2.2 North America Protein Drugs Market Size by Type (2022-2027) 6.2.3 North America Protein Drugs Market Size by Type (2016-2027) 6.3 North America Protein Drugs Market Size by Application 6.3.1 North America Protein Drugs Market Size by Application (2016-2021) 6.3.2 North America Protein Drugs Market Size by Application (2022-2027) 6.3.3 North America Protein Drugs Market Size by Application (2016-2027) 6.4 North America Protein Drugs Market Size by Country 6.4.1 North America Protein Drugs Market Size by Country (2016-2021) 6.4.2 North America Protein Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Protein Drugs Market Size (2016-2027) 7.2 Europe Protein Drugs Market Size by Type 7.2.1 Europe Protein Drugs Market Size by Type (2016-2021) 7.2.2 Europe Protein Drugs Market Size by Type (2022-2027) 7.2.3 Europe Protein Drugs Market Size by Type (2016-2027) 7.3 Europe Protein Drugs Market Size by Application 7.3.1 Europe Protein Drugs Market Size by Application (2016-2021) 7.3.2 Europe Protein Drugs Market Size by Application (2022-2027) 7.3.3 Europe Protein Drugs Market Size by Application (2016-2027) 7.4 Europe Protein Drugs Market Size by Country 7.4.1 Europe Protein Drugs Market Size by Country (2016-2021) 7.4.2 Europe Protein Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Protein Drugs Market Size (2016-2027) 8.2 Asia-Pacific Protein Drugs Market Size by Type 8.2.1 Asia-Pacific Protein Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Protein Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Protein Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Protein Drugs Market Size by Application 8.3.1 Asia-Pacific Protein Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Protein Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Protein Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Protein Drugs Market Size by Region 8.4.1 Asia-Pacific Protein Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Protein Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Protein Drugs Market Size (2016-2027) 9.2 Latin America Protein Drugs Market Size by Type 9.2.1 Latin America Protein Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Protein Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Protein Drugs Market Size by Type (2016-2027) 9.3 Latin America Protein Drugs Market Size by Application 9.3.1 Latin America Protein Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Protein Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Protein Drugs Market Size by Application (2016-2027) 9.4 Latin America Protein Drugs Market Size by Country 9.4.1 Latin America Protein Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Protein Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Protein Drugs Market Size (2016-2027) 10.2 Middle East & Africa Protein Drugs Market Size by Type 10.2.1 Middle East & Africa Protein Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Protein Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Protein Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Protein Drugs Market Size by Application 10.3.1 Middle East & Africa Protein Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Protein Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Protein Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Protein Drugs Market Size by Country 10.4.1 Middle East & Africa Protein Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Protein Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly 11.1.1 Eli Lilly Company Details 11.1.2 Eli Lilly Business Overview 11.1.3 Eli Lilly Protein Drugs Introduction 11.1.4 Eli Lilly Revenue in Protein Drugs Business (2016-2021) 11.1.5 Eli Lilly Recent Development 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Company Details 11.2.2 Abbott Laboratories Business Overview 11.2.3 Abbott Laboratories Protein Drugs Introduction 11.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2016-2021) 11.2.5 Abbott Laboratories Recent Development 11.3 UCB Group 11.3.1 UCB Group Company Details 11.3.2 UCB Group Business Overview 11.3.3 UCB Group Protein Drugs Introduction 11.3.4 UCB Group Revenue in Protein Drugs Business (2016-2021) 11.3.5 UCB Group Recent Development 11.4 Schering-Plough Corporation 11.4.1 Schering-Plough Corporation Company Details 11.4.2 Schering-Plough Corporation Business Overview 11.4.3 Schering-Plough Corporation Protein Drugs Introduction 11.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2016-2021) 11.4.5 Schering-Plough Corporation Recent Development 11.5 Genentech 11.5.1 Genentech Company Details 11.5.2 Genentech Business Overview 11.5.3 Genentech Protein Drugs Introduction 11.5.4 Genentech Revenue in Protein Drugs Business (2016-2021) 11.5.5 Genentech Recent Development 11.6 Johnson＆Johnson 11.6.1 Johnson＆Johnson Company Details 11.6.2 Johnson＆Johnson Business Overview 11.6.3 Johnson＆Johnson Protein Drugs Introduction 11.6.4 Johnson＆Johnson Revenue in Protein Drugs Business (2016-2021) 11.6.5 Johnson＆Johnson Recent Development 11.7 Bristol-Myers Squibb 11.7.1 Bristol-Myers Squibb Company Details 11.7.2 Bristol-Myers Squibb Business Overview 11.7.3 Bristol-Myers Squibb Protein Drugs Introduction 11.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2016-2021) 11.7.5 Bristol-Myers Squibb Recent Development 11.8 Novo Nordisk 11.8.1 Novo Nordisk Company Details 11.8.2 Novo Nordisk Business Overview 11.8.3 Novo Nordisk Protein Drugs Introduction 11.8.4 Novo Nordisk Revenue in Protein Drugs Business (2016-2021) 11.8.5 Novo Nordisk Recent Development 11.9 Biogen Idec 11.9.1 Biogen Idec Company Details 11.9.2 Biogen Idec Business Overview 11.9.3 Biogen Idec Protein Drugs Introduction 11.9.4 Biogen Idec Revenue in Protein Drugs Business (2016-2021) 11.9.5 Biogen Idec Recent Development 11.10 Dendreon Corporation 11.10.1 Dendreon Corporation Company Details 11.10.2 Dendreon Corporation Business Overview 11.10.3 Dendreon Corporation Protein Drugs Introduction 11.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2016-2021) 11.10.5 Dendreon Corporation Recent Development 11.11 Amgen Inc. 11.11.1 Amgen Inc. Company Details 11.11.2 Amgen Inc. Business Overview 11.11.3 Amgen Inc. Protein Drugs Introduction 11.11.4 Amgen Inc. Revenue in Protein Drugs Business (2016-2021) 11.11.5 Amgen Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Protein Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Antibody Drugs Table 3. Key Players of Peptide Hormones Table 4. Key Players of Blood Products Table 5. Key Players of Enzymes Table 6. Global Protein Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Protein Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Protein Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Protein Drugs Market Share by Regions (2016-2021) Table 10. Global Protein Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Protein Drugs Market Share by Regions (2022-2027) Table 12. Protein Drugs Market Trends Table 13. Protein Drugs Market Drivers Table 14. Protein Drugs Market Challenges Table 15. Protein Drugs Market Restraints Table 16. Global Protein Drugs Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Protein Drugs Market Share by Players (2016-2021) Table 18. Global Top Protein Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Protein Drugs as of 2020) Table 19. Ranking of Global Top Protein Drugs Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Protein Drugs Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Protein Drugs Product Solution and Service Table 23. Date of Enter into Protein Drugs Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Protein Drugs Market Size by Type (2016-2021) (US$ Million) Table 26. Global Protein Drugs Revenue Market Share by Type (2016-2021) Table 27. Global Protein Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Protein Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Protein Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Protein Drugs Revenue Market Share by Application (2016-2021) Table 31. Global Protein Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Protein Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Protein Drugs Market Size by Type (2016-2021) (US$ Million) Table 34. North America Protein Drugs Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Protein Drugs Market Size by Application (2016-2021) (US$ Million) Table 36. North America Protein Drugs Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Protein Drugs Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Protein Drugs Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Protein Drugs Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Protein Drugs Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Protein Drugs Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Protein Drugs Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Protein Drugs Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Protein Drugs Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Protein Drugs Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Protein Drugs Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Protein Drugs Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Protein Drugs Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Protein Drugs Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Protein Drugs Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Protein Drugs Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Protein Drugs Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Protein Drugs Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Protein Drugs Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Protein Drugs Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Protein Drugs Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Protein Drugs Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Protein Drugs Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Protein Drugs Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Protein Drugs Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Protein Drugs Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Protein Drugs Market Size by Country (2022-2027) & (US$ Million) Table 63. Eli Lilly Company Details Table 64. Eli Lilly Business Overview Table 65. Eli Lilly Protein Drugs Product Table 66. Eli Lilly Revenue in Protein Drugs Business (2016-2021) & (US$ Million) Table 67. Eli Lilly Recent Development Table 68. Abbott Laboratories Company Details Table 69. Abbott Laboratories Business Overview Table 70. Abbott Laboratories Protein Drugs Product Table 71. Abbott Laboratories Revenue in Protein Drugs Business (2016-2021) & (US$ Million) Table 72. Abbott Laboratories Recent Development Table 73. UCB Group Company Details Table 74. UCB Group Business Overview Table 75. UCB Group Protein Drugs Product Table 76. UCB Group Revenue in Protein Drugs Business (2016-2021) & (US$ Million) Table 77. UCB Group Recent Development Table 78. Schering-Plough Corporation Company Details Table 79. Schering-Plough Corporation Business Overview Table 80. Schering-Plough Corporation Protein Drugs Product Table 81. Schering-Plough Corporation Revenue in Protein Drugs Business (2016-2021) & (US$ Million) Table 82. Schering-Plough Corporation Recent Development Table 83. Genentech Company Details Table 84. Genentech Business Overview Table 85. Genentech Protein Drugs Product Table 86. Genentech Revenue in Protein Drugs Business (2016-2021) & (US$ Million) Table 87. Genentech Recent Development Table 88. Johnson＆Johnson Company Details Table 89. Johnson＆Johnson Business Overview Table 90. Johnson＆Johnson Protein Drugs Product Table 91. Johnson＆Johnson Revenue in Protein Drugs Business (2016-2021) & (US$ Million) Table 92. Johnson＆Johnson Recent Development Table 93. Bristol-Myers Squibb Company Details Table 94. Bristol-Myers Squibb Business Overview Table 95. Bristol-Myers Squibb Protein Drugs Product Table 96. Bristol-Myers Squibb Revenue in Protein Drugs Business (2016-2021) & (US$ Million) Table 97. Bristol-Myers Squibb Recent Development Table 98. Novo Nordisk Company Details Table 99. Novo Nordisk Business Overview Table 100. Novo Nordisk Revenue in Protein Drugs Business (2016-2021) & (US$ Million) Table 101. Novo Nordisk Recent Development Table 102. Biogen Idec Company Details Table 103. Biogen Idec Business Overview Table 104. Biogen Idec Protein Drugs Product Table 105. Biogen Idec Revenue in Protein Drugs Business (2016-2021) & (US$ Million) Table 106. Biogen Idec Recent Development Table 107. Dendreon Corporation Company Details Table 108. Dendreon Corporation Business Overview Table 109. Dendreon Corporation Protein Drugs Product Table 110. Dendreon Corporation Revenue in Protein Drugs Business (2016-2021) & (US$ Million) Table 111. Dendreon Corporation Recent Development Table 112. Amgen Inc. Company Details Table 113. Amgen Inc. Business Overview Table 114. Amgen Inc. Protein Drugs Product Table 115. Amgen Inc. Revenue in Protein Drugs Business (2016-2021) & (US$ Million) Table 116. Amgen Inc. Recent Development Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Global Protein Drugs Market Share by Type: 2020 VS 2027 Figure 2. Antibody Drugs Features Figure 3. Peptide Hormones Features Figure 4. Blood Products Features Figure 5. Enzymes Features Figure 6. Global Protein Drugs Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. Clinics Case Studies Figure 9. Other Case Studies Figure 10. Protein Drugs Report Years Considered Figure 11. Global Protein Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Protein Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Protein Drugs Market Share by Regions: 2020 VS 2027 Figure 14. Global Protein Drugs Market Share by Regions (2022-2027) Figure 15. Global Protein Drugs Market Share by Players in 2020 Figure 16. Global Top Protein Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Protein Drugs as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Protein Drugs Revenue in 2020 Figure 18. Global Protein Drugs Revenue Market Share by Type (2016-2021) Figure 19. Global Protein Drugs Revenue Market Share by Type (2022-2027) Figure 20. North America Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Protein Drugs Market Share by Type (2016-2027) Figure 22. North America Protein Drugs Market Share by Application (2016-2027) Figure 23. North America Protein Drugs Market Share by Country (2016-2027) Figure 24. United States Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Protein Drugs Market Share by Type (2016-2027) Figure 28. Europe Protein Drugs Market Share by Application (2016-2027) Figure 29. Europe Protein Drugs Market Share by Country (2016-2027) Figure 30. Germany Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Protein Drugs Market Share by Type (2016-2027) Figure 38. Asia-Pacific Protein Drugs Market Share by Application (2016-2027) Figure 39. Asia-Pacific Protein Drugs Market Share by Region (2016-2027) Figure 40. China Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Protein Drugs Market Share by Type (2016-2027) Figure 48. Latin America Protein Drugs Market Share by Application (2016-2027) Figure 49. Latin America Protein Drugs Market Share by Country (2016-2027) Figure 50. Mexico Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Protein Drugs Market Share by Type (2016-2027) Figure 54. Middle East & Africa Protein Drugs Market Share by Application (2016-2027) Figure 55. Middle East & Africa Protein Drugs Market Share by Country (2016-2027) Figure 56. Turkey Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Protein Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Eli Lilly Revenue Growth Rate in Protein Drugs Business (2016-2021) Figure 60. Abbott Laboratories Revenue Growth Rate in Protein Drugs Business (2016-2021) Figure 61. UCB Group Revenue Growth Rate in Protein Drugs Business (2016-2021) Figure 62. Schering-Plough Corporation Revenue Growth Rate in Protein Drugs Business (2016-2021) Figure 63. Genentech Revenue Growth Rate in Protein Drugs Business (2016-2021) Figure 64. Johnson＆Johnson Revenue Growth Rate in Protein Drugs Business (2016-2021) Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Protein Drugs Business (2016-2021) Figure 66. Novo Nordisk Revenue Growth Rate in Protein Drugs Business (2016-2021) Figure 67. Biogen Idec Revenue Growth Rate in Protein Drugs Business (2016-2021) Figure 68. Dendreon Corporation Revenue Growth Rate in Protein Drugs Business (2016-2021) Figure 69. Amgen Inc. Revenue Growth Rate in Protein Drugs Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Eli Lilly Abbott Laboratories UCB Group Schering-Plough Corporation Genentech Johnson＆Johnson Bristol-Myers Squibb Novo Nordisk Biogen Idec Dendreon Corporation Amgen Inc.